Eligible participants were randomly assigned ( @:@ ) via computer-generated permuted block randomisation to rifampicin @ mg twice daily or matching placebo ( @ mg riboflavin capsules ) , stratified by subtype ( parkinsonian vs cerebellar ) , with a block size of four .